Abstract
Suramin, at non-cytotoxic doses, reverses chemoresistance and enhances the activity of mitomycin C (MMC) in mice bearing human bladder xenograft tumors. The present study evaluated the pharmacokinetics of the intravesical suramin and MMC, alone or in combination, in dogs. Animals received either high dose suramin (20 mg/ml), low dose suramin (6 mg/ml), MMC (2 mg/ml), or combination of low dose suramin and MMC, instilled for 2 h. The dosing volume was 20 ml. All groups showed dilution of drug levels over time due to continued urine production. For single agent suramin, the results showed (a) 5% to 10% penetration into bladder tissues, (b) minimal and clinically insignificant systemic absorption (i.e., undetectable at low dose or a peak concentration that was 6,000× lower than urine concentrations), and (c) disproportionally higher drug penetration and concentrations in bladder tissues at the higher dose. Results for single agent MMC are consistent with our earlier observations. The co-administration of MMC did not alter the plasma, urine, or tissue pharmacokinetics of suramin. Adding suramin did not alter plasma or tissue pharmacokinetics of MMC, but lowered the MMC concentrations in urine by about 20%. This may be in part due t...Continue Reading
References
Feb 1, 1991·Pharmaceutical Research·M G WientjesJ L Au
Sep 15, 1989·Biochemical Pharmacology·E L VansterkenburgL H Janssen
Jan 1, 1986·Journal of Clinical Pharmacology·J M CollinsC E Myers
Nov 1, 1994·The Journal of Urology·M M WaltherW M Linehan
Jan 1, 1993·Cancer Chemotherapy and Pharmacology·M G WientjesJ L Au
Jan 1, 1997·Cancer Chemotherapy and Pharmacology·D SongJ L Au
Jul 13, 2000·Proceedings of the National Academy of Sciences of the United States of America·S SongJ L Au
Oct 24, 2000·Life Sciences·W P McNallyL R Whitfield
Apr 20, 2001·Journal of the National Cancer Institute·J L AuUNKNOWN International Mitomycin C Consortium
Dec 13, 2002·The Journal of Urology·Edward M UchioMcClellan M Walther
Aug 2, 2003·BMC Clinical Pharmacology·David G Levitt
Dec 14, 2004·Pharmaceutical Research·Adam OgdenJessie L S Au
Jun 2, 2005·British Journal of Cancer·J J OrdA L Harris
Jun 11, 2005·The Journal of Urology·Yan XinJessie L-S Au
Jul 16, 2005·Scandinavian Journal of Urology and Nephrology·Frank G E Perabo, Stefan C Müller
Mar 29, 2008·Pharmaceutical Research·Zancong ShenJessie L-S Au
Jul 18, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M A Villalona-CaleroJ L-S Au
Oct 1, 2008·Clinical Genitourinary Cancer·Saby GeorgeRonald M Bukowski
Jan 29, 2010·Cancer Chemotherapy and Pharmacology·Elaine T LamMiguel A Villalona-Calero
Citations
Dec 22, 2015·The Journal of Urology·Lori Birder
May 29, 2012·European Urology·Renzo ColomboFrancesco Montorsi
Oct 22, 2016·Urologia·Mauro RagoneseSalvatore M Recupero
Dec 20, 2013·Environmental Technology·Ahmed E M AbdelazizPatrick C Hallenbeck
May 26, 2017·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Andrew S MikhailBradford J Wood